CAPTRUST Financial Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$194K	Buy	55,157 +8,345	+18%	+$26.7K	﹤0.01%	2696
2025 Q4	$128K	Buy	46,812 +5,563	+13%	+$12.9K	﹤0.01%	2585
2025 Q3	$89.5K	Buy	41,249 +17,481	+74%	+$41.3K	﹤0.01%	2520
2025 Q2	$40.9K	Buy	23,768 +645	+3%	+$1.6K	﹤0.01%	2446
2025 Q1	$77K	Sell	23,123 -5,615	-20%	-$29K	﹤0.01%	2259
2024 Q4	$213K	Sell	28,738 -20,868	-42%	-$193K	﹤0.01%	2112
2024 Q3	$466K	Buy	49,606 +24,171	+95%	+$229K	﹤0.01%	1609
2024 Q2	$204K	Sell	25,435 -24,589	-49%	-$264K	﹤0.01%	2031
2024 Q1	$741K	Buy	50,024 +14,556	+41%	+$169K	﹤0.01%	1290
2023 Q4	$288K	Buy	+35,468	New	+$186K	﹤0.01%	2137
2022 Q3	–	Sell	-1,474	Closed	-$16K	–	3038
2022 Q2	$16K	Sell	1,474 -340	-19%	-$4.46K	﹤0.01%	3495
2022 Q1	$30K	Buy	1,814 +496	+38%	+$7.67K	﹤0.01%	3147
2021 Q4	$25K	Sell	1,318 -81	-6%	-$1.78K	﹤0.01%	3139
2021 Q3	$34K	Buy	1,399 +339	+32%	+$7.99K	﹤0.01%	2827
2021 Q2	$28K	Buy	1,060 +81	+8%	+$2.1K	﹤0.01%	2884
2021 Q1	$31K	Buy	979 +279	+40%	+$11.6K	﹤0.01%	2722
2020 Q4	$32K	Hold	700	–	–	﹤0.01%	2035
2020 Q3	$24K	Hold	700	–	–	﹤0.01%	1894
2020 Q2	$20K	Buy	+700	New	+$23K	﹤0.01%	1938